reAlpha Acquires GTG Financial, Inc. - ReAlpha Tech ( NASDAQ:AIRE )
DUBLIN, Ohio, Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- reAlpha Tech Corp. ( "reAlpha" ) AIRE, a real estate technology company developing and commercializing artificial intelligence ( "AI" ) technologies, today announced the acquisition of GTG Financial, Inc. ( "GTG Financial" ) , a mortgage ...
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025 - Phathom Pharmaceuticals ( NASDAQ:PHAT )
Management to host conference call on Thursday, March 6, 2025, at 8:30 am ET FLORHAM PARK, N.J., Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Phathom Pharmaceuticals, Inc.
Apollo to Acquire Bridge Investment Group - Apollo Global Management ( NYSE:APO ) , Bridge Investment Group ( NYSE:BRDG )
Scaled Investment Platform Expands Apollo's Origination Capabilities in Residential and Industrial Real Estate Bridge Manages $50 Billion of High-Quality AUM in Complementary Sectors Aligned with Apollo's Long-Term Growth Strategy
Douglas Dynamics Appoints New President of Work Truck Attachments - Douglas Dynamics ( NYSE:PLOW )
MILWAUKEE, Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Douglas Dynamics, Inc. PLOW, North America's premier manufacturer and upfitter of work truck attachments and equipment, today announced the appointment of Chris Bernauer as President of Work Truck Attachments, effective February 28, 2025.
Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version - Co-Diagnostics ( NASDAQ:CODX )
Co-Diagnostics withdrew its 510 ( k ) application for its COVID-19 test to submit an enhanced version addressing shelf-life stability concerns. The new submission will incorporate platform improvements, aiming for greater operational and manufacturing efficiencies across Co-Dx tests.
Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease - Teva Pharmaceutical Indus ( NYSE:TEVA ) , Sanofi ( NASDAQ:SNY )
In ulcerative colitis, duvakitug led to clinical remission in up to 48% of patients, with placebo-adjusted rates of 27% at the highest dose. In Crohn's disease, duvakitug achieved endoscopic response in up to 48% of patients, with placebo-adjusted rates of 35% at the highest dose.
How To Earn $500 A Month From ONEOK Stock Ahead Of Q4 Earnings - ONEOK ( NYSE:OKE )
A more conservative goal of $100 monthly dividend income would require 291 shares of ONEOK. An investor would need to own $142,834 worth of ONEOK to generate a monthly dividend income of $500. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, and real-time ...
Fresh Del Monte Stock Falls As Q4 Sales & Earnings Miss Expectations - Fresh Del Monte Produce ( NYSE:FDP )
Fresh Del Monte Produce Q4 sales of $1.01 billion and adjusted EPS of $0.26 miss estimates. Board approves dividend hike and a $150 million share repurchase program. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, and real-time market insights.
